These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 15476578

  • 1. Intermittent ibandronate preserves bone quality and bone strength in the lumbar spine after 16 months of treatment in the ovariectomized cynomolgus monkey.
    Müller R, Hannan M, Smith SY, Bauss F.
    J Bone Miner Res; 2004 Nov; 19(11):1787-96. PubMed ID: 15476578
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys.
    Smith SY, Recker RR, Hannan M, Müller R, Bauss F.
    Bone; 2003 Jan; 32(1):45-55. PubMed ID: 12584035
    [Abstract] [Full Text] [Related]

  • 4. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A, Tanaka M, Nozaki K, Mori M, Fukushima S, Mori H, Shiroya T, Nakamura T.
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M, Mori H, Kayasuga R, Ochi Y, Kawada N, Yamada H, Kishikawa K.
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [Abstract] [Full Text] [Related]

  • 7. Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys.
    Mori H, Tanaka M, Kayasuga R, Masuda T, Ochi Y, Yamada H, Kishikawa K, Ito M, Nakamura T.
    Bone; 2008 Nov; 43(5):840-8. PubMed ID: 18718565
    [Abstract] [Full Text] [Related]

  • 8. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
    Gasser JA, Ingold P, Venturiere A, Shen V, Green JR.
    J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
    [Abstract] [Full Text] [Related]

  • 9. Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.
    Ominsky MS, Stouch B, Schroeder J, Pyrah I, Stolina M, Smith SY, Kostenuik PJ.
    Bone; 2011 Aug; 49(2):162-73. PubMed ID: 21497676
    [Abstract] [Full Text] [Related]

  • 10. Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid.
    Glatt M, Pataki A, Evans GP, Hornby SB, Green JR.
    Osteoporos Int; 2004 Sep; 15(9):707-15. PubMed ID: 15024556
    [Abstract] [Full Text] [Related]

  • 11. Treatment of skeletally mature ovariectomized rhesus monkeys with PTH(1-84) for 16 months increases bone formation and density and improves trabecular architecture and biomechanical properties at the lumbar spine.
    Fox J, Miller MA, Newman MK, Turner CH, Recker RR, Smith SY.
    J Bone Miner Res; 2007 Feb; 22(2):260-73. PubMed ID: 17087625
    [Abstract] [Full Text] [Related]

  • 12. Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged rats.
    Shahnazari M, Yao W, Dai W, Wang B, Ionova-Martin SS, Ritchie RO, Heeren D, Burghardt AJ, Nicolella DP, Kimiecik MG, Lane NE.
    Bone; 2010 May; 46(5):1267-74. PubMed ID: 19931661
    [Abstract] [Full Text] [Related]

  • 13. Effects of treatment with parathyroid hormone 1-84 on quantity and biomechanical properties of thoracic vertebral trabecular bone in ovariectomized rhesus monkeys.
    Fox J, Newman MK, Turner CH, Guldberg RE, Varela A, Smith SY.
    Calcif Tissue Int; 2008 Mar; 82(3):212-20. PubMed ID: 18297227
    [Abstract] [Full Text] [Related]

  • 14. Treatment with the combination of ibandronate plus eldecalcitol has a synergistic effect on inhibition of bone resorption without suppressing bone formation in ovariectomized rats.
    Sakai S, Takeda S, Sugimoto M, Shimizu M, Shimonaka Y, Yogo K, Hashimoto J, Bauss F, Endo K.
    Bone; 2015 Dec; 81():449-458. PubMed ID: 26281770
    [Abstract] [Full Text] [Related]

  • 15. Three-dimensional modeling of the effects of parathyroid hormone on bone distribution in lumbar vertebrae of ovariectomized cynomolgus macaques.
    Sato M, Westmore M, Clendenon J, Smith S, Hannum B, Zeng GQ, Brommage R, Turner CH.
    Osteoporos Int; 2000 Dec; 11(10):871-80. PubMed ID: 11199192
    [Abstract] [Full Text] [Related]

  • 16. Intermittent Ibandronate Maintains Bone Mass, Bone Structure, and Biomechanical Strength of Trabecular and Cortical Bone After Discontinuation of Parathyroid Hormone Treatment in Ovariectomized Rats.
    Takeda S, Sakai S, Tanaka K, Tomizawa H, Serizawa K, Yogo K, Urayama K, Hashimoto J, Endo K, Matsumoto Y.
    Calcif Tissue Int; 2017 Jul; 101(1):65-74. PubMed ID: 28246925
    [Abstract] [Full Text] [Related]

  • 17. Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption.
    Doyle N, Varela A, Haile S, Guldberg R, Kostenuik PJ, Ominsky MS, Smith SY, Hattersley G.
    Osteoporos Int; 2018 Mar; 29(3):685-697. PubMed ID: 29260289
    [Abstract] [Full Text] [Related]

  • 18. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY.
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [Abstract] [Full Text] [Related]

  • 19. The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats.
    Kurth AH, Eberhardt C, Müller S, Steinacker M, Schwarz M, Bauss F.
    Bone; 2005 Aug; 37(2):204-10. PubMed ID: 15936997
    [Abstract] [Full Text] [Related]

  • 20. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements.
    Wang ML, Massie J, Perry A, Garfin SR, Kim CW.
    Spine J; 2007 Aug; 7(4):466-74. PubMed ID: 17630145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.